Secondary abdominal pregnancy and its associated diagnostic and operative dilemma: three case reports by Gupta, Pratiksha et al.
Case report
Open Access
Secondary abdominal pregnancy and its associated diagnostic and
operative dilemma: three case reports
Pratiksha Gupta*, Alka Sehgal, Anju Huria and Reeti Mehra
Address: Department of Obstetrics and Gynecology, Government Medical College and Hospital Sector 32B, Chandigarh, 160030, India
Email: PG* - drpratiksha@gmail.com; AS - alkasehgal@rediffmail.com; AH - anjuhuria@yahoo.com; RM - drreetidatta@yahoo.co.in
*Corresponding author
Received: 9 September 2008 Accepted: 27 January 2009 Published: 7 August 2009
Journal of Medical Case Reports 2009, 3:7382 doi: 10.4076/1752-1947-3-7382
This article is available from: http://jmedicalcasereports.com/jmedicalcasereports/article/view/7382
© 2009 Gupta et al.; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Abdominal pregnancy is extremely rare and has historically been defined as an
implantation in the peritoneal cavity, exclusive of tubal, ovarian or intraligamentary pregnancy.
Case presentations: Threecasesarereported.Allcamefromalowermiddle-incomegroupandallof
them were subjected to surgery. The first patient was a 30-year-old woman, who was pregnant for the
fourth time, who presented at 16 weeks with an abdominal pregnancy. She was admitted with constant
abdominal pain and retention of urine. She was hemodynamically stable and was administered a
pre-operative intramuscular injection of methotrexate. During laparotomy she had only minor blood
loss, the major part of the placenta was removed easily and she did not require any blood transfusion.
Serum beta human chorionic gonadotrophin values and ultrasound follow-up revealed a normal study
four weeks after surgery. The second patient was a 26-year-old woman, pregnant for the third time,
admitted at 14 weeks with an abdominal pregnancy with hemoperitoneum, and the third patient was a
24-year-old woman, pregnant for the first time, who presented at 36 weeks gestation. She was only
diagnosed as having an abdominal pregnancy during surgery, experienced excessive blood loss and
required a longer hospital stay.
Conclusions: We hypothesize that treatment with pre-operative systemic methotrexate with
subsequent laparotomy for removal of the fetus and placenta may minimize potential blood loss, and
would be a reasonable approach in the care of a patient with an abdominal pregnancy with placental
implantation to the abdominal viscera and blood vessels. This treatment option should be considered
in the management of this potentially life-threatening condition. During surgery, if the placenta is
attached to vital organs it should be left behind. Early diagnosis can help in reducing associated
maternal morbidity and mortality.
Introduction
Abdominal pregnancy has historically been defined as an
implantation in the peritoneal cavity, exclusive of tubal,
ovarian or intraligamentary pregnancy [1]. Abdominal
pregnancy is a rare obstetric complication with high mat-
ernal mortality and even higher perinatal mortality, and it
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common type. Primary peritoneal implantation is rare.
Studdiford established three criteria for diagnosing pri-
mary peritoneal pregnancies: (1) normal bilateral fallo-
pian tubes and ovaries; (2) the absence of uteroperitoneal
fistula, and (3) a pregnancy related exclusively to the
peritoneal surface and early enough to eliminate the
possibility of secondary implantation following a primary
nidation in the tube [2]. Secondary abdominal pregnancy
is a condition where the embryo or fetus continues to grow
in the abdominal cavity after its expulsion from the
fallopian tube or other seat of its primary development.
Secondary abdominal pregnancy almost always follows
early rupture of a tubal ectopic pregnancy into the
peritoneal cavity with the incidence being 1 in 10,000
live births [3]. Advanced abdominal pregnancy is rare and
accounts for 1 in 25,000 pregnancies [4]. Risk factors for
abdominal pregnancy are the same as for ectopic
pregnancy and, when it is recognized, immediate lapar-
otomy with removal of the fetus is usually recommended.
As it is a life-threatening condition, expectant manage-
ment carries a risk of sudden life-threatening intra-
abdominal bleeding and a generally poor fetal prognosis
[5]. Proper pre-operative evaluation and diagnostic
techniques can help ensure a timely diagnosis, and pre-
operative treatment such as embolization and metho-
trexate administration to minimize blood loss during
surgery can facilitate maximal placental removal. Pre-
operative methotrexate treatment has been described for
abdominal pregnancy by Worley et al. [1] but their
experience was limited to one patient who was given
daily methotrexate therapy. However, sudden placental
separation with acute hemorrhage developed after 4 days
and they had to resort to emergency laparotomy. However,
in one of our patients, pre-operative methotrexate
permitted near total removal of the placenta with no
major complications. Postoperative methotrexate admin-
istration has been recommended by some if the placenta is
left in situ. Others have condemned such a practice,
suggesting that rapid placental destruction leads to an
accumulation of necrotic debris, inviting bacterial growth
[6,7]. Rahaman et al. [6] described five patients treated
postoperatively with methotrexate. Although they had
rapidly declining urinary gonadotrophin levels, all five
developed severe intra-abdominal infections with mortal-
ity in two patients. Methotrexate as a folate antagonist
causes acute intracellular deficiency of these folate co-
enzymes, thus affecting synthesis of DNA especially in
rapidly multiplying cells. Methotrexate acts on rapidly
dividing cells and it is likely to have limited effects on the
mature placenta with its limited proliferative activity. With
or without its utilization, the retained placenta will
frequently undergo suppuration and require surgical
removal. In cases where placental implantation has
occurred in vascular areas such as the mesentery and vital
organs, it has been recommended that the placenta should
be left in situ, because surgical excision can result in
uncontrollable and life-threatening hemorrhage [8]. We
report a patient with a live 16-week pregnancy where a pre-
operative intramuscular dose of methotrexate was given.
She suffered minimal blood loss at laparotomy and major
placental tissue could be removed and she did not require
bloodtransfusion.Thesecondpatientpresentedasanacute
emergencyandsurgerywasundertakenimmediately.Inthe
third case the patient had repeated admissions to our
hospital starting from 32 weeks onwards but the diagnosis
was missed, resulting in fetal death and massive blood loss
during surgery with associated morbidity.
Case presentations
Case 1
A 30-year-old woman (fourth gravida, G4 P2 L2 A1)
presented to our hospital emergency department with
amenorrhea, retention of urine, constipation and abdom-
inal pain. On examination, mild pallor was present and
she was hemodynamically stable. Abdominal examination
revealed a suprapubic mass with tenderness and guarding.
On vaginal examination the cervix was pushed anteriorly,
the uterus was acutely retroverted, and a separate tender
mass of a 16-week size was felt. Transvaginal sonogram
revealed an empty uterine cavity with a live fetus of
16 weeks gestation, which was lying in the pouch of
Douglas. The placenta was seen anteriorly and above the
uterine fundus and no myometrium was defined around
the fetus and placenta. A diagnosis of secondary abdom-
inal pregnancy was made. The patient was given a systemic
injection of methotrexate administered intramuscularly at
a dose of 50 mg/m
2. Elective laparotomy was undertaken
48 hours later. During surgery the fetus and gestational sac
were seen lying in the pouch of Douglas and the placenta
was adherent to the right fallopian tube, the fundus of the
uterus, the omentum and thebowel. Extraction of thefetus
with placental removal and partial omentectomy was
carried out. One-third of the placenta was left behind as it
was judged not safe to remove it. Blood loss during surgery
was around 200 mL and the patient required no transfu-
sion. The postoperative period was uneventful and she was
discharged on the 10th postoperative day. Serum beta
human chorionic gonadotrophin levels returned to
normal after three weeks and ultrasound examination
revealed complete resorption of the placenta at around
four weeks.
Case 2
A 26-year-old woman, third gravida, with two previous
full-term vaginal deliveries, was admitted on 13th May
2008. Her last menstrual period was on 26th February
2008 and bilateral tubal ligation was done in March 2008.
Her symptomatology started a month after ligation when
she had lower abdominal pain. Her urine pregnancy test
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wasperformedon29thApril.Twodaysbeforeadmissionto
hospital her pain increased in severity and was associated
with fever and painful micturition. At admission she had
moderate anemia, tachycardia and hypotension. Abdom-
inal examination revealed free fluid in the abdominal
cavity. Per-vaginal examination revealed a normal size
uterus with tenderness and an ill-defined mass in the right
adnexa. An ultrasound showed an intraperitoneal fluid
collection,anormalsizeuterusandalivefetusof14-weeks’
gestation, which was lying in the pouch of Douglas.
Abdominal paracentesis confirmed hemoperitoneum.
Intra-operative findings revealed the placenta to be
attached to the omentum, the bowel and the posterior
surface and the right cornua of the uterus. Partial
omentectomy was performed and part of the placenta
was left behind. Two units of blood were transfused. The
patient did well postoperatively and complete placental
resorption took approximately six weeks.
Case 3
A 24-year-old woman, primigravida, was admitted to our
hospital with abdominal pain at 32 weeks of pregnancy
with anemia and mild abdominal pain. She had two units
of blood for her anemia and ultrasound examination
reportedaliveintrauterinepregnancywithplacentapraevia.
Shewasdischargedafterherpainsubsided.Thispatienthad
repeated hospital admissionsstarting at around14weeksof
gestational age for constant abdominal pain, for which
uterine colic was diagnosed and analgesics were prescribed
each time. She had sudden loss of fetal movement at 39
weeks of pregnancy and ultrasound revealed intrauterine
fetal demise with a low-lying placenta. Spontaneous onset
of labor did not happen, and at 41+1 weeks of pregnancy
induction of labor was started. The cervix failed to ripen in
spite of maximum doses of prostaglandin and her uterus
also failedtostimulatewithoxytocin.She wasthentaken to
surgeryforcaesariansectionforfailedinduction.Duringthe
surgery secondary abdominal pregnancy was diagnosed
with the fetus seen lying in the abdominal cavity and
the placenta was adherent to the omentum and the bowel.
The fetus was extracted and during removal of the placenta
the patient had torrential bleeding so that only one-quarter
of the placenta could be removed. The bleeding was
controlled by packing and pressure. The patient received
seven units of whole blood during the surgery. She was
discharged on postoperative day 20 without any major
complications. Follow-up was done by measuring serum
betahumanchorionicgonadotrophinlevelsandultrasound
examination; it took six months for complete absorption of
the placenta.
Discussion
Abdominal pregnancy is a rare obstetric complication with
high maternal and perinatal mortality. Ultrasound,
magnetic resonance imaging (MRI), computed tomogra-
phy (CT) scan and laparotomy can help in differentiating
between primary and secondary abdominal pregnancy [9].
As early rupture of tubal ectopic pregnancy is the usual
antecedent of a secondary abdominal pregnancy, a sug-
gestive history can usually be obtained. These include
spotting or irregular bleeding along with abdominal pain,
nausea, vomiting, flatulence, constipation, diarrhea and
abdominal pain, all in varying degrees. Fetal malpresenta-
tion, extreme anterior displacement of the cervix, failure of
spontaneous onset of labor and artificial induction of
labor are common complications. Appreciable cervical
effacement is also unusual in these patients. Small fetal
parts may be palpated through the vaginal fornices and
identified clearly outside the uterus [5]. The patient with
an abdominal pregnancy typically presents with constant
abdominal pain; two of our patients sought medical
attention for this and initial evaluation showed them to be
hemodynamically stable. About 50% of diagnoses are
missed on ultrasound [10] but MRI and CT are both
excellent diagnostic tools to diagnose secondary abdom-
inal pregnancy [3,5]. In our first and second patients, the
clinical diagnoses were supported by ultrasound examina-
tion, but the third patient was misdiagnosed, ending in
fetal death. She had typical signs and symptoms of
constant abdominal pain, progressive anemia and sudden
fetal death. She also had failed induction of labor, which
could have clinched the diagnosis but it was missed.
CT scan or MRI could have diagnosed this patient pre-
operatively and pre-operative methotrexate could have
been planned and resulted in less blood loss during
placental separation and hence reduced maternal morbid-
ity. It should be noted that even in cases where it is the
surgeon’s intent to leave the placenta in situ, serious
hemorrhage can occur because of inadvertent disruption
of the placental blood supply in the process of fetal
removal. This is likely due to the unpredictable nature of
the placental blood supply, as well as the difficult surgical
challenges presented by extensive adhesion formation
typically found in abdominal pregnancy. Successful
control of hemorrhage after removal of the fetus and
placenta at laparotomy depends upon the various treat-
ment protocols used pre- and intra-operatively. Even
pre-operative embolization of vessels supplying the
placental bed has been tried by some surgeons, thus
decreasing intra-operative blood loss associated with
removal of the fetus and placenta [6].
During laparotomy the clinician must make a decision
concerning the fate of the placenta. Postoperative
maternal morbidity will probably be lessened by total
removal of the placenta if this is technically feasible and
this should be possible using proper pre-operative
treatment modalities such as embolization or systemic
methotrexate. If vascular attachment involves major
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disturbed [8]. Postoperative methotrexate has been
administered by some for placental absorption but it
leads to accumulation of necrotic tissue due to accelerated
placental absorption and increases morbidity [5,6,7].
Retention of the placenta in situ is not without its
attendant risks and postoperative morbidity can be
substantial. Secondary hemorrhage, abscess formation,
paralytic ileus, bowel obstruction, pre-eclampsia and
eclampsia have all been reported as complications of
leaving the placenta in situ [11]. Any modality which can
offer a reduction of intra-operative vascularity and hence
blood loss would be a boon for these patients. Where the
facility for embolization is not easily accessible, injectable
methotrexate is an easy, cheap and relatively safer option.
Resorption of a placenta left in situ has been reported to
be a slow process and can be followed either by sono-
graphy, MRI or CT scan. Visualization of a hyperechoic
placental mass has been reported as late as five years after
delivery [12]. Although no consensus regarding the
treatment of the placenta in abdominal pregnancy has
been established, most authors advocate leaving the
placenta in situ unless the surgeon can be confidently
assured that the entire blood supply to the placental bed
can be surgically ligated without loss of excessive
amounts of blood, and the need for extensive blood
replacement therapy. Pre-operative arterial embolization
has also been advocated by some [6]. We successfully
managed to remove more than half of a placenta without
significant blood loss and without the patient requiring
blood transfusion. A literature review shows that in one
report an 18-week abdominal pregnancy was managed
by percutaneous sonographically guided intracardiac
injection of potassium chloride followed by uncompli-
cated laparotomy with complete removal of the fetus and
placenta [13]. In another study, the patient was managed
at 19 weeks of pregnancy by sonographically guided intra-
cardiac potassium chloride with an intramuscular injec-
tion of 50 mg/m
2 methotrexate. This patient had no
surgical intervention and complete resorption occurred
over a period of 1.5 years [11].
Many authors have described pregnancies carried to term
with live births, various fetal congenital malformations,
poor fetal outcome and high neonatal mortality [4,5] and
even minimally invasive surgeries have been tried up to
the second trimester of pregnancy [6,14,15].
The treatment options for patients with abdominal
pregnancies are dependent on various factors and the
availability of resources. Pre-operative arterial emboliza-
tion would have been the first choice in our patients but
due to lack of facilities we resorted to pre-operative
intramuscular methotrexate. Other pre-operative consid-
erations include the insertion of ureteric catheters, bowel
preparation,assuranceofsufficientbloodproductsandthe
availability of a multidisciplinary surgical team. Should
such resources not be available, elective transfer of a
woman with a known advanced extra-uterine pregnancy to
a tertiary care facility is appropriate. If discovery is not
made until attempted cesarean delivery, even then a safer
alternative would be to defer delivery if possible, close the
abdominal incision, and transfer the woman to an
appropriate hospital. This could be done even after the
delivery of the fetus or neonate with the placenta left in situ
if there was no bleeding [1].
We propose that pre-operative systemic methotrexate with
subsequent laparotomy for removal of the fetus and
placenta may minimize potential blood loss, and may be a
reasonable approach in the care of a patient with an
abdominal pregnancy with placental implantation to
abdominal viscera and blood vessels. This treatment
option could be considered in the management of this
potentially life-threatening condition, but more reports
and experience are required. Proper pre-operative evalua-
tion with appropriate diagnostic techniques can help with
a timely diagnosis, and pre-operative treatment such as
methotrexate administration to minimize blood loss at
surgery can facilitate maximal placental removal. As the
placenta continues to grow throughout the pregnancy
methotrexate is recommended at all gestational ages.
Conclusion
Proper pre-operative evaluation and pre-operative sys-
temic methotrexate, assurance of sufficient blood pro-
ducts, availability of a multidisciplinary surgical team and
proper operative techniques in managing abdominal
pregnancy can reduce maternal morbidity.
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